Solentim Revenue and Competitors

Wimborne,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Solentim's estimated annual revenue is currently $2M per year.(i)
  • Solentim's estimated revenue per employee is $155,000

Employee Data

  • Solentim has 13 Employees.(i)
  • Solentim grew their employee count by -43% last year.

Solentim's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Human Resources ManagerReveal Email/Phone
3
Global Marketing ManagerReveal Email/Phone
4
Field Applications ScientistReveal Email/Phone
5
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Solentim?

Solentim is the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, including cell and gene therapies, monoclonal antibodies, vaccines and stem cells. For our customers, which include most of the world's leading pharmaceutical and biotherapeutics companies, we are the partner of choice for facilitating the highest level of assurance in cell line development for therapeutic protein and viral vector production. Our portfolio of proven and innovative instruments (including VIPS™, Cell Metric® and Cell Metric® CLD) are designed for single cell cloning and assurance of monoclonality. Combined with enabling reagents (including InstiGRO™ and Leap-In Transposase®) from our partners, and our unparalleled domain expertise, we transform the speed and efficiency of clonally-derived Master Cell Bank development. Our customers trust in our technology to ensure they are confidently prepared for regulatory review. Products Cell Metric®: High contrast imager for single cell identification and clonal outgrowth characterization Cell Metric® CLD: Premium version of the Cell Metric® with built-in, incubated plate loader for unattended imaging of 10 plates in a cassette VIPS™: High-efficiency, single-cell seeder with image-based assurance of clonality Partners ATUM: Atum's Leap-In Transposase® technology, when coupled with VIPS™, eliminates the need to pre-screen or select in-line for high producing clones, saving time and money, and enhancing workflow efficiency SAL Scientific: InstiGRO™ supplements are proven to show improved cell growth, colony formation and cloning efficiency ValitaCell: Working on an integrated platform to deposit, culture, profile and select optimal cells for the manufacture of life-saving biological medicines

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-43%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.7M230%N/A
#2
$8.8M3812%N/A
#3
$12.5M576%N/A
#4
$38.8M110-1%N/A
#5
$85.7M381N/AN/A